These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29419804)

  • 1. Alpha-Difluoromethylornithine, an Irreversible Inhibitor of Polyamine Biosynthesis, as a Therapeutic Strategy against Hyperproliferative and Infectious Diseases.
    LoGiudice N; Le L; Abuan I; Leizorek Y; Roberts SC
    Med Sci (Basel); 2018 Feb; 6(1):. PubMed ID: 29419804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport.
    Samal K; Zhao P; Kendzicky A; Yco LP; McClung H; Gerner E; Burns M; Bachmann AS; Sholler G
    Int J Cancer; 2013 Sep; 133(6):1323-33. PubMed ID: 23457004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma.
    Bassiri H; Benavides A; Haber M; Gilmour SK; Norris MD; Hogarty MD
    Transl Pediatr; 2015 Jul; 4(3):226-38. PubMed ID: 26835380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor DL-alpha-difluoromethylornithine.
    Merali S; Clarkson AB
    Antimicrob Agents Chemother; 1996 Apr; 40(4):973-8. PubMed ID: 8849262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ornithine Decarboxylase Inhibition: A Strategy to Combat Various Diseases.
    Somani RR; Rai PR; Kandpile PS
    Mini Rev Med Chem; 2018; 18(12):1008-1021. PubMed ID: 28971766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
    Meyskens FL; Gerner EW
    Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insight into DFMO resistant ornithine decarboxylase from Entamoeba histolytica: an inkling to adaptive evolution.
    Preeti ; Tapas S; Kumar P; Madhubala R; Tomar S
    PLoS One; 2013; 8(1):e53397. PubMed ID: 23326423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithine.
    Qu N; Ignatenko NA; Yamauchi P; Stringer DE; Levenson C; Shannon P; Perrin S; Gerner EW
    Biochem J; 2003 Oct; 375(Pt 2):465-70. PubMed ID: 12859253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent.
    Raul F
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):353-5. PubMed ID: 17371277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention in prostate cancer: the role of difluoromethylornithine (DFMO).
    Kadmon D
    J Cell Biochem Suppl; 1992; 16H():122-7. PubMed ID: 1289667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-difluoromethylornithine (DFMO) as a potent arginase activity inhibitor in human colon carcinoma cells.
    Selamnia M; Mayeur C; Robert V; Blachier F
    Biochem Pharmacol; 1998 Apr; 55(8):1241-5. PubMed ID: 9719479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-ray structure of ornithine decarboxylase from Trypanosoma brucei: the native structure and the structure in complex with alpha-difluoromethylornithine.
    Grishin NV; Osterman AL; Brooks HB; Phillips MA; Goldsmith EJ
    Biochemistry; 1999 Nov; 38(46):15174-84. PubMed ID: 10563800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies on difluoromethylornithine in African trypanosomes.
    McCann PP; Bacchi CJ; Clarkson AB; Seed JR; Nathan HC; Amole BO; Hutner SH; Sjoerdsma A
    Med Biol; 1981 Dec; 59(5-6):434-40. PubMed ID: 6175860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difluoromethylornithine in cancer: new advances.
    Alexiou GA; Lianos GD; Ragos V; Galani V; Kyritsis AP
    Future Oncol; 2017 Apr; 13(9):809-819. PubMed ID: 28125906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyamines as biomarkers of cervical intraepithelial neoplasia.
    Nishioka K; Melgarejo AB; Lyon RR; Mitchell MF
    J Cell Biochem Suppl; 1995; 23():87-95. PubMed ID: 8747382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibition of pathogenic yeast isolates by alpha-difluoromethylornithine: an inhibition of ornithine decarboxylase.
    Pfaller MA; Gerarden T; Riley J
    Mycopathologia; 1987 Apr; 98(1):3-8. PubMed ID: 3108666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to DL-alpha-difluoromethylornithine by clinical isolates of Trypanosoma brucei rhodesiense. Role of S-adenosylmethionine.
    Bacchi CJ; Garofalo J; Ciminelli M; Rattendi D; Goldberg B; McCann PP; Yarlett N
    Biochem Pharmacol; 1993 Aug; 46(3):471-81. PubMed ID: 8347171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by alpha-difluoromethylornithine.
    Takigawa M; Verma AK; Simsiman RC; Boutwell RK
    Cancer Res; 1983 Aug; 43(8):3732-8. PubMed ID: 6407752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probenecid increases renal retention and antitumor activity of DFMO in neuroblastoma.
    Schultz CR; Swanson MA; Dowling TC; Bachmann AS
    Cancer Chemother Pharmacol; 2021 Oct; 88(4):607-617. PubMed ID: 34129075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implications.
    Thomas T; Thomas TJ
    Breast Cancer Res Treat; 1994 Feb; 29(2):189-201. PubMed ID: 8012036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.